Inferior Alveolar Nerve Block
7
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
The Optimal Injection Site for a 3D Guided Inferior Alveolar Nerve Block Device (IANBD)
Effect of AI-Supported Child-Friendly Communication on Dental Anxiety in Pediatric Patients
Warm Versus Conventional 2% Lignocaine for IANB Efficacy
Comparison of the Computer Controlled and Conventional Local Anesthesia Techniques in Primary Molar Extraction in Children Aged 5 to 9 Years Old
A Novel Technique to Anaesthetize the Lower Jaw
Pain and Anxiety Control During Traditional Mandibular Anesthesia in Children Using Distracting Tools
Evaluation of Use of Ultrasound for Greater Palatine Nerve Block and Inferior Alveolar Nerve Blocks: An Open Label Feasibility Study